Some investors asked Remite on the interactive platform. 1. How does the new 301 tariff policy implemented by the US on July 24 affect your company's business and performance in the US, and does the company have countermeasures? 2. Does the company consider applying separately for tariff exemptions for related products from USTR due to lack of alternative sources in the US? Remite replied that the company's products entered the US market in accordance with the law. At present, the US tariff policy on China has little impact on core indicators such as revenue, net profit, and gross margin of the company and US exclusive agent React Health in the US region. The company continues to pay attention to policy trends and maintains close communication with customers, and various businesses are progressing in an orderly manner.

Some investors asked Remite on the interactive platform. 1. How does the new 301 tariff policy implemented by the US on July 24 affect your company's business and performance in the US, and does the company have countermeasures? 2. Does the company consider applying separately for tariff exemptions for related products from USTR due to lack of alternative sources in the US? Remite replied that the company's products entered the US market in accordance with the law. At present, the US tariff policy on China has little impact on core indicators such as revenue, net profit, and gross margin of the company and US exclusive agent React Health in the US region. The company continues to pay attention to policy trends and maintains close communication with customers, and various businesses are progressing in an orderly manner.